KINGFA: Monitoring Agency Report for Quarter Ended March 31, 2026 Shows No Deviation in ₹500 Crore Preferential Issue
Kingfa Science & Technology (India) Limited's Monitoring Agency Report for the quarter ended March 31, 2026, indicates no deviation in the utilization of proceeds from its ₹500 crore preferential issue. ₹40.63 crore was utilized towards General Corporate Purpose (GCP) during Q4FY26. The unutilized amount stands at ₹344.22 crore, invested in fixed deposits. The completion date for the projects is June 2027.
The announcement is a routine compliance report on the utilization of funds, with no significant impact on the company's operations or stock performance.
The announcement is factual and reports on the monitoring of funds utilization with no indication of positive or negative performance.
Kingfa Science & Technology (India) Limited has released the Monitoring Agency Report for the quarter ended March 31, 2026. The report, issued by CARE Ratings Limited, pertains to the utilization of issue proceeds from the company’s preferential issue aggregating to ₹500 crore. This is pursuant to Regulation 32(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The report is in relation to the preferential issue of Kingfa Science & Technology India Limited.
The report indicates that there were no deviations from the objects for which the funds were raised. During Q4FY26, ₹40.63 crore was utilized towards GCP (General Corporate Purpose). The total unutilized amount is ₹344.22 crore, which is deployed in fixed deposits and savings accounts with ICBC (Industrial and Commercial Bank of China Limited). The completion date for Phase 2 Factory, Office Administration, Plant and Machinery, Land Acquisition and General Corporate Purpose is June 2027.
The monitoring agency, CARE Ratings Limited, declared that the report provides an objective view of the utilization of the issue proceeds based on the information provided by the issuer and information obtained from sources believed to be accurate and reliable.
What to do with a filing like this
Kingfa Science & Technology (India) Limited filed this with the NSE as a statutory disclosure, categorised under preferential allotment. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Kingfa Science & Technology (India) Limited. Read the original for the full detail.